## Abstract We present the results obtained using low doses of clozapine (mean dose 26.4 mg at bedtime) in the treatment of noctural akathisia in nine patients with Parkinson's disease for a mean period of 12.5 months. The results were excellent in all the patients. Furthermore, three patients expe
Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease
✍ Scribed by Christian Prueter; Benedikt Habermeyer; Christine Norra; Christoph M. Kosinski
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 43 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Due to its low profile for extrapyramidal side‐effects, quetiapine has become an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease (PD). We describe the case of a patient with PD who developed severe akathisia, a common complication with classical antipsychotics, with quetiapine. © 2003 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract This double‐blind randomized study examined the effect of quetiapine (QTP) on drug‐induced psychosis (DIP) in Parkinson's disease (PD). Conventional antipsychotic drugs are associated with adverse extrapyramidal effects. QTP is a new atypical antipsychotic drug used in the treatment of
## Abstract The loss of beneficial effect of levodopa due to progression of the disease and alteration of receptor sensitivity makes the treatment of the advanced stadium of Parkinson's disease (PD) very difficult. In the past “drug holidays” was used in attempt to resensitize dopamine receptors in